KZIA Kazia Therapeutics
- 0.275
- -0.007-2.55%
Kazia Therapeutics News
Kazia Therapeutics Shares Are Trading Lower. The Company Announced the Completion of the EVT801 Phase 1 Clinical Trial.
Kazia Therapeutics Shares Are Trading Lower. The Company Announced the Completion of the EVT801 Phase 1 Clinical Trial.
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS
Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that the Safety Review Team (SRT) ...
Kazia Therapeutics Ltd Entered Into Purchase Agreement With Alumni Capital LP; Pursuant To Purchase Agreement, May Sell To Alumni Capital Up To $15M Of American Depositary Shares From Time To Time
Kazia Therapeutics Ltd Entered Into Purchase Agreement With Alumni Capital LP; Pursuant To Purchase Agreement, May Sell To Alumni Capital Up To $15M Of American Depositary Shares From Time To Time
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Shares of NextPlat Corp (NASDAQ:NXPL) rose sharply in today's pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year NextPlat shares surged
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Byrna Technologies Inc. (NASDAQ:BYRN) rose sharply during Friday's session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition. Byrna Techno
Kazia Therapeutics Licenses Paxalisib To Sovargen For Intractable Seizures In Rare Central Nervous System Diseases
Kazia Therapeutics Licenses Paxalisib To Sovargen For Intractable Seizures In Rare Central Nervous System Diseases
Kazia Presents Data At AACR Annual Meeting
Kazia Presents Data At AACR Annual Meeting
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersEnveric Biosciences (NASDAQ:ENVB) shares increased by 83.5% to $1.56 during Friday's pre-market session. The company's market cap stands at $4.2 million. Telesis Bio (NASDAQ:TBIO) stock increas
Kazia Therapeutics' Lead Drug Candidate Meets Goal of Early-Stage Study
Kazia Therapeutics (KZIA) on Wednesday said its lead drug candidate paxalisib met the primary goal of an early-stage clinical trial sooner than expected. The two-part phase 1 trial established the saf
What's Going With Australia-Based Cancer Firm Kazia Therapeutics On Wednesday?
Wednesday morning, Kazia Therapeutics Limited (NASDAQ:KZIA) announced the early conclusion based on safety and clinical response findings observed to date of an important two-part Phase 1 trial. Durin
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersEmergent BioSolutions (NYSE:EBS) stock increased by 77.0% to $2.69 during Wednesday's regular session. The market value of their outstanding shares is at $139.5 million. Ventyx Biosciences (NAS
Kazia Concludes Phase 1 Study for Paxalisib Early Due to Promising Data
Kazia Reports Positive Phase I Trial Results for Brain Cancer Therapy
Kazia Therapeutics Limited (NASDAQ: KZIA), an Australian biotechnology firm, has announced the early conclusion of a Phase I clinical trial due to positive safety and clinical response findings.
Kazia Therapeutics Announced The Early Conclusion Based On Safety And Clinical Response Findings Observed To Date From A Two-part Phase 1 Trial Of Paxalisib With Radiation Therapy For PI3K Pathway Mutation Brain Metastases From Solid Tumors
Kazia Therapeutics Announced The Early Conclusion Based On Safety And Clinical Response Findings Observed To Date From A Two-part Phase 1 Trial Of Paxalisib With Radiation Therapy For PI3K Pathway Mut
Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint
Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specializing in oncology, today announced the early conclusion based on positive...
12 Health Care Stocks Moving In Friday's After-Market Session
GainersVirpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 13.3% to $0.37 during Friday's after-market session. The market value of their outstanding shares is at $4.3 million. Dyadic Internation
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSocietal CDMO (NASDAQ:SCTL) shares moved upwards by 23.4% to $0.57 during Wednesday's pre-market session. The market value of their outstanding shares is at $59.7 million. Apollomics (NASDAQ:AP
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersOnconetix (NASDAQ:ONCO) stock increased by 152.6% to $0.37 during Thursday's pre-market session. The market value of their outstanding shares is at $8.2 million. Acutus Medical (NASDAQ:AFIB) st
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAcutus Medical (NASDAQ:AFIB) shares rose 49.2% to $0.34 during Wednesday's after-market session. The market value of their outstanding shares is at $9.9 million. Kazia Therapeutics (NASDAQ:KZIA
12 Health Care Stocks Moving In Monday's After-Market Session
GainersCadrenal Therapeutics (NASDAQ:CVKD) shares moved upwards by 8.5% to $1.15 during Monday's after-market session. The market value of their outstanding shares is at $14.9 million. vTv Therapeutic
Analysis
Price Target
No Data
